Back to top
more

Clorox (CLX)

(Delayed Data from NYSE)

$162.77 USD

162.77
960,238

+0.07 (0.04%)

Updated Nov 7, 2024 04:00 PM ET

After-Market: $162.84 +0.07 (0.04%) 7:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 15% (37 out of 251)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Clorox (CLX) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Clorox's (CLX) third-quarter fiscal 2020 results are expected to reflect gains from the increase in demand for disinfecting wipes and floor cleaners due to the coronavirus outbreak.

Clorox (CLX) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights: Clorox, Manning & Napier, Virtu Financial, PLDT and The Scotts Miracle-Gro

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Clorox, Manning & Napier, Virtu Financial, PLDT and The Scotts Miracle-Gro

3 Momentum Anomaly Stocks in Focus Amid Coronavirus Turmoil

by Zacks Equity Research

These fast movers are currently witnessing a short-term pullback in price as COVID-19 rattles market participants. So, this could possibly be a great entry point for reaping better returns.

Retirees Should Know These 3 Facts About Required Minimum Distributions - April 23, 2020

by Zacks Equity Research

Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.

How Clorox (CLX) Stock Stands Out in a Strong Industry

by Zacks Equity Research

Clorox (CLX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Sreoshi Bera headshot

Coronavirus Ravages US Employment Boom: 5 Safe Stocks to Buy

by Sreoshi Bera

Surge in jobless claims for four consecutive weeks calls for investment in these five recession-proof stocks.

Clorox (CLX) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, Clorox (CLX) closed at $191.67, marking a +0.47% move from the previous day.

Is The Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?

by Zacks Equity Research

Is (CLX) Outperforming Other Consumer Staples Stocks This Year?

Kimberly-Clark (KMB) Q1 Earnings Top Estimates, Sales up

by Zacks Equity Research

Kimberly-Clark (KMB) generates robust cost savings in first-quarter 2020. However, management withdraws its 2020 guidance due to coronavirus outbreak.

What's in the Cards for Keurig Dr Pepper's (KDP) Q1 Earnings?

by Zacks Equity Research

Keurig Dr Pepper's (KDP) first-quarter 2020 performance is likely to reflect gains from innovation and marketing of key brands. However, growth investments are likely to entail high costs.

Nalak Das headshot

5 Top High-Yielding Stocks With Double-Digit Returns YTD

by Nalak Das

A closer look into Wall Street will give us a number of good stocks that have offered double-digit returns so far this year.

James Giaquinto headshot

3 Stocks on the Rise During the Coronavirus

by James Giaquinto

3 Stocks on the Rise During the Coronavirus

Clorox (CLX) Stock Moves -0.89%: What You Should Know

by Zacks Equity Research

Clorox (CLX) closed at $190.71 in the latest trading session, marking a -0.89% move from the prior day.

Hershey (HSY) to Report Q1 Earnings: Key Factors to Note

by Zacks Equity Research

Benefits from innovation and acquisitions are likely to get reflected in Hershey's (HSY) first-quarter 2020 performance. Also, focus on efficient pricing strategies bodes well.

Coca-Cola (KO) Q1 Earnings & Revenues Surpass Estimates

by Zacks Equity Research

Coca-Cola (KO) reports robust first-quarter 2020 results, driven by strong performance in North America and Latin America through February, offset by declines in China due to the coronavirus outbreak.

Things to Note Ahead of Kimberly-Clark's (KMB) Q1 Earnings

by Zacks Equity Research

Increased demand owing to panic-buying trends amid the coronavirus outbreak is likely to get reflected in Kimberly-Clark's (KMB) first-quarter 2020 performance.

What's in the Offing for Boston Beer (SAM) in Q1 Earnings?

by Zacks Equity Research

Boston Beer's (SAM) first-quarter 2020 results are likely to reflect gains from increased depletions and shipments. However, the effects of the virus outbreak might have impacted its performance.

Procter & Gamble (PG) Q3 Earnings Beat Estimates, Sales Up

by Zacks Equity Research

Procter & Gamble's (PG) bottom line beats estimates in third-quarter fiscal 2020, while sales meet the same. Free cash flow productivity increases to 113%.

Things You Must Know Ahead of Philip Morris' (PM) Q1 Earnings

by Zacks Equity Research

Philip Morris' (PM) first-quarter 2020 performance is likely to reflect favorable pricing and gains from RRPs. However, soft cigarette volumes might have been a concern.

Coca-Cola (KO) to Report Q1 Earnings: What's in the cards?

by Zacks Equity Research

Coca-Cola's (KO) first-quarter 2020 results are expected to reflect the impacts of the coronavirus outbreak in China beginning January.

Sanghamitra Saha headshot

Coronavirus Ruins March Retail Sales: Top & Flop ETF Areas

by Sanghamitra Saha

March retail sales saw a record decline due to the coronavirus-led economic shutdown. These ETF areas won/lost in the month.

Clorox (CLX) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Clorox (CLX) closed the most recent trading day at $195.75, moving +0.71% from the previous trading session.

Factors Setting Tone for Procter & Gamble's (PG) Q3 Earnings

by Zacks Equity Research

Procter & Gamble's (PG) third-quarter fiscal 2020 results are expected to reflect gains from continued operations of its facilities despite the coronavirus outbreak.

The Zacks Analyst Blog Highlights: Meritage Homes, Sarepta Therapeutics, The Clorox Company, The Hain Celestial Group and Entergy

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Meritage Homes, Sarepta Therapeutics, The Clorox Company, The Hain Celestial Group and Entergy